5AM’s portfolio of advanced life science technologies is diversified within the healthcare industry’s biopharmaceutical, medical, technology, and research instrument sectors. Within each sector, 5AM evaluates innovative platform technologies, corporate spin-offs and products with shorter development cycles and invests across multiple therapeutic areas.